These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20716057)

  • 1. Inhibition of glycogenolysis towards antidiabetic and other therapies.
    Somsák L
    Mini Rev Med Chem; 2010 Oct; 10(12):1091-2. PubMed ID: 20716057
    [No Abstract]   [Full Text] [Related]  

  • 2. In the Search of Glycoside-Based Molecules as Antidiabetic Agents.
    Pałasz A; Cież D; Trzewik B; Miszczak K; Tynor G; Bazan B
    Top Curr Chem (Cham); 2019 Jun; 377(4):19. PubMed ID: 31165274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.
    Ogawa AK; Willoughby CA; Bergeron R; Ellsworth KP; Geissler WM; Myers RW; Yao J; Harris G; Chapman KT
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3405-8. PubMed ID: 14505637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen phosphorylase inhibitors.
    Henke BR; Sparks SM
    Mini Rev Med Chem; 2006 Aug; 6(8):845-57. PubMed ID: 16918491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the allosteric inhibition of glycogen phosphorylase.
    Loughlin WA
    Mini Rev Med Chem; 2010 Oct; 10(12):1139-55. PubMed ID: 20716052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glycogen phosphorylase in the context of type 2 diabetes, with focus on recent inhibitors bound at the active site.
    Praly JP; Vidal S
    Mini Rev Med Chem; 2010 Oct; 10(12):1102-26. PubMed ID: 20716051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computation as a tool for glycogen phosphorylase inhibitor design.
    Hayes JM; Leonidas DD
    Mini Rev Med Chem; 2010 Oct; 10(12):1156-74. PubMed ID: 20716053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in glycogen phosphorylase inhibitor design.
    Oikonomakos NG; Somsák L
    Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of
    Barr D; Szennyes E; Bokor É; Al-Oanzi ZH; Moffatt C; Kun S; Docsa T; Sipos Á; Davies MP; Mathomes RT; Snape TJ; Agius L; Somsák L; Hayes JM
    ACS Chem Biol; 2019 Jul; 14(7):1460-1470. PubMed ID: 31243960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined in silico and in vitro studies to identify novel antidiabetic flavonoids targeting glycogen phosphorylase.
    Brás NF; Neves RPP; Lopes FAA; Correia MAS; Palma AS; Sousa SF; Ramos MJ
    Bioorg Chem; 2021 Mar; 108():104552. PubMed ID: 33357981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of N-glucopyranosidic derivatives as potential inhibitors that bind at the catalytic site of glycogen phosphorylase.
    Gimisis T
    Mini Rev Med Chem; 2010 Oct; 10(12):1127-38. PubMed ID: 20716054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases.
    Zhang L; Chen J; Gong Y; Liu J; Zhang L; Hua W; Sun H
    Chem Biodivers; 2009 Jun; 6(6):864-74. PubMed ID: 19551727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New inhibitors of glycogen phosphorylase as potential antidiabetic agents.
    Somsák L; Czifrák K; Tóth M; Bokor E; Chrysina ED; Alexacou KM; Hayes JM; Tiraidis C; Lazoura E; Leonidas DD; Zographos SE; Oikonomakos NG
    Curr Med Chem; 2008; 15(28):2933-83. PubMed ID: 19075645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase.
    Kato A; Nasu N; Takebayashi K; Adachi I; Minami Y; Sanae F; Asano N; Watson AA; Nash RJ
    J Agric Food Chem; 2008 Jun; 56(12):4469-73. PubMed ID: 18494482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site.
    Hampson LJ; Arden C; Agius L; Ganotidis M; Kosmopoulou MN; Tiraidis C; Elemes Y; Sakarellos C; Leonidas DD; Oikonomakos NG
    Bioorg Med Chem; 2006 Dec; 14(23):7835-45. PubMed ID: 16908161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
    Goyard D; Kónya B; Chajistamatiou AS; Chrysina ED; Leroy J; Balzarin S; Tournier M; Tousch D; Petit P; Duret C; Maurel P; Somsák L; Docsa T; Gergely P; Praly JP; Azay-Milhau J; Vidal S
    Eur J Med Chem; 2016 Jan; 108():444-454. PubMed ID: 26708111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A convenient synthesis of novel pyranosyl homo-C-nucleosides and their antidiabetic activities.
    Bisht SS; Jaiswal N; Sharma A; Fatima S; Sharma R; Rahuja N; Srivastava AK; Bajpai V; Kumar B; Tripathi RP
    Carbohydr Res; 2011 Jul; 346(10):1191-201. PubMed ID: 21550025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glycogen metabolism: a novel strategy to inhibit cancer cell growth?
    Favaro E; Harris AL
    Oncotarget; 2013 Jan; 4(1):3-4. PubMed ID: 23448808
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycogen phosphorylase inhibitors: a patent review (2013 - 2015).
    Donnier-Maréchal M; Vidal S
    Expert Opin Ther Pat; 2016; 26(2):199-212. PubMed ID: 26666989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'-axial CH2 OH substitution on glucopyranose does not increase glycogen phosphorylase inhibitory potency. QM/MM-PBSA calculations suggest why.
    Manta S; Xipnitou A; Kiritsis C; Kantsadi AL; Hayes JM; Skamnaki VT; Lamprakis C; Kontou M; Zoumpoulakis P; Zographos SE; Leonidas DD; Komiotis D
    Chem Biol Drug Des; 2012 May; 79(5):663-73. PubMed ID: 22296957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.